Search

Author/Creator Riefflin, Axel

1. Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Issue 7 (20th April 2018)

Authors:
Reed, Shelby D.; Li, Yanhong; Leal, Jose; Radican, Larry; Adler, Amanda I.; Alfredsson, Joakim; Buse, John B.; Green, Jennifer B.; Kaufman, Keith D.; Riefflin, Axel; Van de Werf, Frans; Peterson, Eric D.; Gray, Alastair M.; Holman, Rury R.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 20:Issue 7(2018)
Page Start:
1732
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS. Issue 11 (7th July 2017)

Authors:
Engel, Samuel S.; Suryawanshi, Shailaja; Stevens, Susanna R.; Josse, Robert G.; Cornel, Jan H.; Jakuboniene, Neli; Riefflin, Axel; Tankova, Tsvetalina; Wainstein, Julio; Peterson, Eric D.; Holman, Rury R.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 19:Issue 11(2017)
Page Start:
1587
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search